Radiopharm Theranostics Limited (ASX:RAD)
Australia · Delayed Price · Currency is AUD 0.0280
+0.0010 (3.70%)
Aug 29, 2025, 3:37 PM AEST
Radiopharm Theranostics Market Cap
Radiopharm Theranostics has a market cap or net worth of 66.22 million as of August 29, 2025. Its market cap has increased by 69.24% in one year.
Market Cap
66.22M
Enterprise Value
35.18M
Revenue
13.54M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.03
Market Cap Chart
Since November 25, 2021, Radiopharm Theranostics's market cap has decreased from 101.33M to 66.22M, a decrease of -34.65%. That is a compound annual growth rate of -10.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 29, 2025 | 66.22M | 25.78% |
| Dec 31, 2024 | 52.65M | 91.43% |
| Dec 29, 2023 | 27.50M | -20.28% |
| Dec 30, 2022 | 34.50M | -65.53% |
| Dec 31, 2021 | 100.07M | -1.25% |
| Nov 25, 2021 | 101.33M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 103.08B |
| Pro Medicus | 31.23B |
| Cochlear | 19.72B |
| Sonic Healthcare | 11.89B |
| Ramsay Health Care | 7.79B |
| Telix Pharmaceuticals | 4.94B |
| Ansell | 4.91B |
| Mesoblast | 2.79B |